"Institut Andrée Dutreix, seul centre de cancérologie intégré du Littoral du Nord et de la Flandre maritime"

During the past decade, Centre D Oncologie Dunkerquois conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre D Oncologie Dunkerquois" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "GERCOR - Multidisciplinary Oncology Cooperative Group" with 1 trials sponsored, "Institut Claudius Regaud" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "University Hospital, Lille" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre D Oncologie Dunkerquois" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator and "University of Lille Nord de France" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Centre D Oncologie Dunkerquois" are "Advanced Biliary Tract Carcinoma" (1 trials), "Colorectal Cancer" (1 trials), "Gastric Adenocarcinoma" (1 trials), "Non-Squamous Non-Small Cell Lung Cancer" (1 trials) and "Oesophageal Carcinoma" (1 trials). Many other conditions were trialed in "Centre D Oncologie Dunkerquois" in a lesser frequency.

Most popular intervention types in "Centre D Oncologie Dunkerquois" are "Other" (2 trials), "Drug" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Archival Tumor Tissue Sample" (1 trials), "Durvalumab" (1 trials), "Experimental arm" (1 trials), "Questionnaire" (1 trials) and "Tremelimumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre D Oncologie Dunkerquois" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Centre D Oncologie Dunkerquois". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Centre D Oncologie Dunkerquois, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre D Oncologie Dunkerquois, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".